MENU
ALGS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aligos Therapeutics (ALGS) Ownership - Who owns Aligos Therapeutics?
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
66
Web
https://www.aligos.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
65.06M
P/E Ratio
N/A
Total Cash
122.95M
Projected Growth
N/A
Total Debt
6.88M
Revenue
3.17M
Risk (Beta)
3.12
Dividend Yield
N/A
Total Cash/Share
17.69
Total Debt/Equity
N/A
Revenue/Share
0.40 USD as % of share price
Fundamentals
ALGS
Capitalization
65.1M
P/E Ratio
N/A
Risk (Beta)
3.12
Dividend Yield
N/A
Total Cash
123M
Total Cash/Share
17.69
Total Debt
6.88M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.40%
Revenue
3.17M
ROE
N/A
Book Value
102M
P/B Ratio
0.64
Cash Flow
N/A
Earnings
-13.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
6.31
Current Revenue Per Employee
13785.71
Dividends Per Share - Security
N/A
EBITDA
-75.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-60.93
Shares Held By Institutions
26.5M
Shares Outstanding - Current
6.95M
Total Liabilities
32.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-76.506
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
66
Web
https://www.aligos.com